{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:26:02Z","timestamp":1760189162158},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T00:00:00Z","timestamp":1298678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00347-010-2260-2","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T07:54:18Z","timestamp":1298534058000},"page":"213-221","source":"Crossref","is-referenced-by-count":5,"title":["Uveitistherapie im Kindesalter"],"prefix":"10.1007","volume":"108","author":[{"given":"F.","family":"Mackensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,26]]},"reference":[{"key":"2260_CR1","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften et al (2008) Leitlinien der Gesellschaft f\u00fcr Kinderheilkunde und Jugendrheumatologie. www.uni-duesseldorf.de\/AWMF\/II\/027-020.htm"},{"key":"2260_CR2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ajo.2007.08.018","volume":"144","author":"Ardoin","year":"2007","unstructured":"Ardoin SP, Kredich D, Rabinovich E et al (2007) Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. Am J Ophthalmol 144:844\u2013849","journal-title":"Am J Ophthalmol"},{"key":"2260_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H et al (2007) Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 91:319\u2013324","journal-title":"Br J Ophthalmol"},{"key":"2260_CR4","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.2174\/138161208786369786","volume":"14","author":"Calogiuri","year":"2008","unstructured":"Calogiuri G, Ventura MT, Mason L et al (2008) Hypersensitivity reactions to last generation chimeric, humanized [correction of umanized] and human recombinant monoclonal antibodies for therapeutic use. Curr Pharm Des 14:2883\u20132891","journal-title":"Curr Pharm Des"},{"key":"2260_CR5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0277-9536(96)00221-3","volume":"44","author":"Charles","year":"1997","unstructured":"Charles C, Gafni A, Whelan T (1997) Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). Soc Sci Med 44:681\u2013692","journal-title":"Soc Sci Med"},{"key":"2260_CR6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907\u2013916","journal-title":"N Engl J Med"},{"key":"2260_CR7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(03)00315-5","volume":"135","author":"Davis","year":"2003","unstructured":"Davis Jl, Dacanay LM, Holland GN et al (2003) Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol 135:763\u2013771","journal-title":"Am J Ophthalmol"},{"key":"2260_CR8","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/art.27511","volume":"62","author":"Diak","year":"2010","unstructured":"Diak P, Siegel J, La Grenade L et al (2010) Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum 62:2517\u20132524","journal-title":"Arthritis Rheum"},{"key":"2260_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jbm.a.31239","volume":"83","author":"Fantazzini","year":"2007","unstructured":"Fantazzini P, Garavaglia C, Gomez S et al (2007) Chondrocyte-alginate bioconstructs: a nuclear magnetic resonance relaxation study. J Biomed Mater Res A 83:345\u2013353","journal-title":"J Biomed Mater Res A"},{"key":"2260_CR10","first-page":"1146","volume":"34","author":"Foeldvari","year":"2007","unstructured":"Foeldvari I, Nielsen S, Kummerle-Deschner J et al (2007) Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34:1146\u20131150","journal-title":"J Rheumatol"},{"key":"2260_CR11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bjo.2007.124081","volume":"91","author":"Gallagher","year":"2007","unstructured":"Gallagher M, Quinones K, Cervantes-Castaneda RA et al (2007) Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol 91:1341\u20131344","journal-title":"Br J Ophthalmol"},{"key":"2260_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2009.173542","volume":"95","author":"Goebel","year":"2011","unstructured":"Goebel JC, Roesel M, Heinz C et al (2011) Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol 95:209\u2013213","journal-title":"Br J Ophthalmol"},{"key":"2260_CR13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1055\/s-2007-963174","volume":"224","author":"Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Horneff G, Greiner K et al (2007) Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood. Klin Monatsbl Augenheilkd 224:526\u2013531","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2260_CR14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/112067210701700509","volume":"17","author":"Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Mingels A, Heinz C et al (2007) Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol 17:743\u2013748","journal-title":"Eur J Ophthalmol"},{"key":"2260_CR15","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Niewerth M, Ganser G et al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 46:1015\u20131019","DOI":"10.1093\/rheumatology\/kem053"},{"key":"2260_CR16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"2260_CR17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ophtha.2006.01.005","volume":"113","author":"Kahn","year":"2006","unstructured":"Kahn P, Weiss M, Imundo LF et al (2006) Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 113:860\u2013864","journal-title":"Ophthalmology"},{"key":"2260_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/j.sempedsurg.2007.04.010","volume":"16","author":"Kayton","year":"2007","unstructured":"Kayton Ml (2007) Cancer and pediatric inflammatory bowel disease. Semin Pediatr Surg 16:205\u2013213","journal-title":"Semin Pediatr Surg"},{"key":"2260_CR19","doi-asserted-by":"crossref","unstructured":"Kenawy N, Cleary G, Mewar D et al (2010) Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis. Graefes Arch Clin Exp Ophthalmol (Oct 5 Epub)","DOI":"10.1007\/s00417-010-1523-6"},{"key":"2260_CR20","first-page":"249","volume":"116","author":"Kilmartin","year":"1998","unstructured":"Kilmartin DJ, Forrester JV, Dick AD (1998) Cyclosporine-induced resolution of choroidal neovascularization associated with sympathetic ophthalmia. Arch Ophthalmol 116:249\u2013250","journal-title":"Arch Ophthalmol"},{"key":"2260_CR21","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","volume":"56","author":"Lim","year":"2007","unstructured":"Lim LL, Fraunfelder FW, Rosenbaum JT (2007) Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 56:3248\u20133252","journal-title":"Arthritis Rheum"},{"key":"2260_CR22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000229759","volume":"72","author":"Minden","year":"2009","unstructured":"Minden K (2009) Adult outcomes of patients with juvenile idiopathic arthritis. Horm Res 72(Suppl 1):20\u201325","journal-title":"Horm Res"},{"key":"2260_CR23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2005.09.037","volume":"113","author":"Rajaraman","year":"2006","unstructured":"Rajaraman RT, Kimura Y, LI S et al (2006) Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology 113:308\u2013314","journal-title":"Ophthalmology"},{"key":"2260_CR24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O","volume":"44","author":"Reiff","year":"2001","unstructured":"Reiff A, Takei S, Sadeghi S et al (2001) Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 44:1411\u20131415","journal-title":"Arthritis Rheum"},{"key":"2260_CR25","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","volume":"111","author":"Rosenberg","year":"2004","unstructured":"Rosenberg KD, Feuer WJ, Davis Jl (2004) Ocular complications of pediatric uveitis. Ophthalmology 111:2299\u20132306","journal-title":"Ophthalmology"},{"key":"2260_CR26","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","volume":"13","author":"Rosh","year":"2007","unstructured":"Rosh JR, Gross T, Mamula P et al (2007) Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn\u2019s disease: a cautionary tale? Inflamm Bowel Dis 13:1024\u20131030","journal-title":"Inflamm Bowel Dis"},{"key":"2260_CR27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","volume":"45","author":"Saurenmann","year":"2006","unstructured":"Saurenmann RK, Levin AV, Rose JB et al (2006) Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology 45:982\u2013989","journal-title":"Rheumatology"},{"key":"2260_CR28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/ard.2006.065441","volume":"66","author":"Sharma","year":"2007","unstructured":"Sharma SM, Ramanan AV, Riley P et al (2007) Use of infliximab in juvenile onset rheumatological disease-associated refractory uveitis: efficacy in joint and ocular disease. Ann Rheum Dis 66:840\u2013841","journal-title":"Ann Rheum Dis"},{"key":"2260_CR29","doi-asserted-by":"crossref","unstructured":"Simonini G, Taddio A, Cattalini M et al (2010) Prevention of flare recurrences in childhood refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res (Hoboken) (Nov 15 Epub)","DOI":"10.1002\/acr.20404"},{"key":"2260_CR30","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/rheumatology\/ken298","volume":"47","author":"Simonini","year":"2008","unstructured":"Simonini G, Zannin ME, Caputo R et al (2008) Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. Rheumatology 47:1510\u20131514","journal-title":"Rheumatology"},{"key":"2260_CR31","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","volume":"116","author":"Smith","year":"2009","unstructured":"Smith JA, Mackensen F, Sen HN et al (2009) Epidemiology and course of disease in childhood uveitis. Ophthalmology 116:1544\u20131551","journal-title":"Ophthalmology"},{"key":"2260_CR32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","volume":"53","author":"Smith","year":"2005","unstructured":"Smith JA, Thompson DJ, Whitcup SM et al (2005) A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 53:18\u201323","journal-title":"Arthritis Rheum"},{"key":"2260_CR33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","volume":"45","author":"Smith","year":"2001","unstructured":"Smith JR, Levinson RD, Holland GN et al (2001) Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 45:252\u2013257","journal-title":"Arthritis Rheum"},{"key":"2260_CR34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/rheumatology\/keq308","volume":"50","author":"Southwood","year":"2011","unstructured":"Southwood TR, Foster He, Davidson JE et al (2011) Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients. Rheumatology 50:184\u2013195","journal-title":"Rheumatology"},{"key":"2260_CR35","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/rheumatology\/kem261","volume":"46","author":"Svenson","year":"2007","unstructured":"Svenson M, Geborek P, Saxne T et al (2007) Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies. Rheumatology 46:1828\u20131834","journal-title":"Rheumatology"},{"key":"2260_CR36","doi-asserted-by":"crossref","unstructured":"Tappeiner C, Roesel M, Heinz C et al (2009) Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye (Lond) 23:1192\u20131198","DOI":"10.1038\/eye.2008.174"},{"key":"2260_CR37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/bjo.2007.136846","volume":"92","author":"Tran","year":"2008","unstructured":"Tran TH, De Smet MD, Bodaghi B et al (2008) Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol 92:922\u2013927","journal-title":"Br J Ophthalmol"},{"key":"2260_CR38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jaapos.2008.08.007","volume":"12","author":"Tugal-Tutkun","year":"2008","unstructured":"Tugal-Tutkun I, Ayranci O, Kasapcopur O et al (2008) Retrospective analysis of children with uveitis treated with infliximab. J AAPOS 12:611\u2013613","journal-title":"J AAPOS"},{"key":"2260_CR39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0161-6420(96)30682-9","volume":"103","author":"Tugal-Tutkun","year":"1996","unstructured":"Tugal-Tutkun I, Havrlikova K, Power WJ et al (1996) Changing patterns in uveitis of childhood. Ophthalmology 103:375\u2013383","journal-title":"Ophthalmology"},{"key":"2260_CR40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10792-009-9310-2","volume":"30","author":"Tugal-Tutkun","year":"2010","unstructured":"Tugal-Tutkun I, Herbort CP (2010) Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol 30:453\u2013464","journal-title":"Int Ophthalmol"},{"key":"2260_CR41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/kem356","volume":"47","author":"Tynjala","year":"2008","unstructured":"Tynjala P, Kotaniemi K, Lindahl P et al (2008) Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology 47:339\u2013344","journal-title":"Rheumatology"},{"key":"2260_CR42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","volume":"66","author":"Tynjala","year":"2007","unstructured":"Tynjala P, Lindahl P, Honkanen V et al (2007) Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 66:548\u2013550","journal-title":"Ann Rheum Dis"},{"key":"2260_CR43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","volume":"149","author":"Vazquez-Cobian","year":"2006","unstructured":"Vazquez-Cobian LB, Flynn T, Lehman TJ (2006) Adalimumab therapy for childhood uveitis. J Peds 149:572\u2013575","journal-title":"J Peds"},{"key":"2260_CR44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0028-1086031","volume":"220","author":"Winterhalter","year":"2008","unstructured":"Winterhalter S, Niehues T (2008) TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? \u2013 An evidence based approach. Klin Padiatr 220:342\u2013347","journal-title":"Klin Padiatr"},{"key":"2260_CR45","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","volume":"Res","author":"Zulian","year":"2010","unstructured":"Zulian F, Balzarin M, Falcini F et al (2010) Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis. Arthritis Care Res (Hoboken) 62:821\u2013825","journal-title":"Arthritis Care"},{"key":"2260_CR46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00347-010-2256-y","volume":"108","author":"Pleyer","year":"2011","unstructured":"Pleyer U, Mackensen F, Winterhalter S et al (2011) Anti-TNF-Therapie bei Uveitis. Eine Standortbestimmung. Ophthalmologe 108:13\u201320","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2260-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-010-2260-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2260-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T16:13:54Z","timestamp":1560010434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-010-2260-2"}},"subtitle":["Biologika: zu oft \u2013 zu sp\u00e4t?"],"short-title":[],"issued":{"date-parts":[[2011,2,26]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["2260"],"URL":"https:\/\/doi.org\/10.1007\/s00347-010-2260-2","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,26]]}}}